SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,070,000 | -67.6% | 125,129 | -43.5% | 0.00% | -62.5% |
| Q4 2021 | $3,302,000 | -22.9% | 221,434 | -0.1% | 0.01% | -27.3% |
| Q3 2021 | $4,281,000 | +1737.3% | 221,738 | +1673.9% | 0.01% | +1000.0% |
| Q2 2021 | $233,000 | -18.0% | 12,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $284,000 | +4.4% | 12,500 | 0.0% | 0.00% | – |
| Q4 2020 | $272,000 | -56.1% | 12,500 | -79.7% | 0.00% | -100.0% |
| Q3 2020 | $620,000 | – | 61,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |